PI
ONC

PFG Investments’s BeOne Medicines Ltd ONC Stock Holding History

PFG Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Hold
1,455
– – 0.02% 762
2026
Q1 		$432K Buy
1,455
+20
+1% +$6.47K 0.02% 671
2025
Q4 		$436K Buy
1,435
+175
+14% +$57.3K 0.02% 624
2025
Q3 		$429K Buy
1,260
+275
+28% +$83.5K 0.02% 600
2025
Q2 		$238K Buy
985
+75
+8% +$18.4K 0.01% 831
2025
Q1 		$248K Buy
+910
New +$213K 0.02% 790
2024
Q4 		– Sell
-935
Closed -$210K – 1092
2024
Q3 		$210K Buy
+935
New +$168K 0.01% 879

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PFG Investments's ONC Position: Q2 2026 in Review

PFG Investments held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 1,455 shares worth $415K. The position accounts for 0.02% of the portfolio, ranked #762.

PFG Investments first reported a position in ONC in Q3 2024 and has held it in 7 quarters since. The position peaked at $436K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • PFG Investments held 1,455 shares of BeOne Medicines Ltd worth $415K as of Q2 2026.
  • PFG Investments left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up 0.02% of PFG Investments's portfolio in Q2 2026, its #762 holding.
  • PFG Investments first reported a position in BeOne Medicines Ltd in Q3 2024 and has held it in 7 quarters since.
  • PFG Investments's BeOne Medicines Ltd position peaked at $436K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.